[1]曾智辉,张建龙,赵立文.达芬奇机器人前列腺癌根治术对患者生存质量及康复的影响[J].医学信息,2023,36(17):93-97.[doi:10.3969/j.issn.1006-1959.2023.17.017]
　ZENG Zhi-hui,ZHANG Jian-long,ZHAO Li-wen.Effect of Da Vinci Robotic-assisted Radical Prostatectomy on Quality of Life and Rehabilitation of Patients with Prostate Cancer[J].Journal of Medical Information,2023,36(17):93-97.[doi:10.3969/j.issn.1006-1959.2023.17.017]
点击复制

达芬奇机器人前列腺癌根治术对患者生存质量及康复的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年17期
页码:
93-97
栏目:
论著
出版日期:
2023-09-01

文章信息/Info

Title:
Effect of Da Vinci Robotic-assisted Radical Prostatectomy on Quality of Life and Rehabilitation of Patients with Prostate Cancer
文章编号:
1006-1959（2023）17-0093-05
作者:
曾智辉; 张建龙; 赵立文
（龙岩市第一医院泌尿外科，福建 龙岩 364000）
Author(s):
ZENG Zhi-hui; ZHANG Jian-long; ZHAO Li-wen
(Department of Urinary Surgery,Longyan First Hospital,Longyan 364000,Fujian,China)
关键词:
达芬奇机器人前列腺癌根治术; 前列腺癌; 生存质量; 勃起功能
Keywords:
Da Vinci robot-assisted radical prostatectomy; Prostate cancer; Quality of life; Erectile function
分类号:
R737.25
DOI:
10.3969/j.issn.1006-1959.2023.17.017
文献标志码:
A
摘要:
目的 研究达芬奇机器人前列腺癌根治术对患者生存质量及康复的影响。方法 选取2021年3月-2022年11月我院行前列腺癌根治术的68例患者为研究对象，采用随机数字表法分为对照组（n=34）和观察组（n=34）。对照组采用常规腹腔镜前列腺癌根治术，观察组采用达芬奇机器人前列腺癌根治术，比较两组临床手术指标、疼痛（VAS）评分、勃起功能评分、阴茎勃起硬度评分、生存质量水平、不同时间段尿控恢复率、并发症发生率。结果 观察组手术时间、尿管拔除时间、住院时间均短于对照组，术中出血量少于对照组（P＜0.05）；观察组VAS评分低于对照组，勃起功能评分、阴茎勃起硬度评分均高于对照组（P＜0.05）；观察组生存质量各维度（生理功能、情感功能、认知功能、社会功能、角色功能）评分均高于对照组（P＜0.05）；观察组术后即刻尿控率、术后1个月尿控率、术后3个月尿控率均高于对照组（P＜0.05）；观察组并发症发生率为5.88%，低于对照组的14.71%（P＜0.05）。结论 达芬奇机器人前列腺癌根治术可改善患者临床手术指标，提高生存质量水平，促进术后康复，预防并发症，提高尿控恢复率，减轻患者疼痛度，提升勃起功能和阴茎勃起硬度，具有相对较理想的临床应用效果。
Abstract:
Objective To investigate the effect of Da Vinci robotic-assisted radical prostatectomy on quality of life and rehabilitation of patients with prostate cancer.Methods A total of 68 patients who underwent radical prostatectomy in our hospital from March 2021 to November 2022 were selected as the research objects. They were divided into control group (n=34) and observation group (n=34) by random number table method. The control group was treated with conventional laparoscopic radical prostatectomy, and the observation group was treated with Da Vinci robot-assisted radical prostatectomy. The clinical operation indexes, pain (VAS) score, erectile function score, penile erectile hardness score, quality of life level, recovery rate of urinary control at different time periods and incidence of complications were compared between the two groups.Results The operation time, catheter removal time and hospitalization time in the observation group were shorter than those in the control group, and the intraoperative blood loss was less than that in the control group (P<0.05). The VAS score of the observation group was lower than that of the control group, and the erectile function score and penile erectile hardness score were higher than those of the control group (P<0.05). The scores of each dimension of quality of life (physiological function, emotional function, cognitive function, social function, role function) in the observation group were higher than those in the control group (P<0.05). The urinary control rate immediately after operation, the urinary control rate at 1 month after operation and the urinary control rate at 3 months after operation in the observation group were higher than those in the control group (P<0.05). The incidence of complications in the observation group was 5.88%, which was lower than 14.71% in the control group (P<0.05).Conclusion Da Vinci robot-assisted radical prostatectomy can improve the clinical operation indexes of patients, improve the quality of life, promote postoperative rehabilitation, prevent complications, improve the recovery rate of urinary control, reduce the pain of patients, improve erectile function and penile erectile hardness, and has relatively ideal clinical application effect.

参考文献/References:

[1]周晓晨,胡兵,傅斌,等.3种机器人辅助腹腔镜根治性前列腺切除术手术入路对比研究:前入路、后入路及经膀胱入路[J].临床泌尿外科杂志,2019,34(7):501-506. [2]王跃,戴波.中国抗癌协会2017版《前列腺癌筛查专家共识》解读[J].临床外科杂志,2018,26(1):15-18.[3]徐柳,张梦洁,庄君龙,等.保留Retzius间隙的机器人前列腺癌根治术在前列腺中叶突出患者中的应用[J].中国肿瘤外科杂志,2019,11(2):83-86,92.[4]许平,王贵荣,高飞.腹腔镜下经腹及经腹膜外入路对前列腺癌根治术患者的近远期疗效分析[J].实用癌症杂志,2019,34(7):1212-1215.[5]贾卓敏,马鑫,艾星,等.达芬奇机器人手术系统在泌尿外科手术中的优势[J].现代泌尿外科杂志,2018,23(5):328-331.[6]Ilic D,Evans SM,Allan CA,et al.Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer[J].Cochrane Database Syst Rev,2017,9(9):CD009625.[7]徐广民.达芬奇机器人与腹腔镜前列腺癌根治术的围术期回顾性调查[J].四川医学,2016(2):160-163.[8]李利军,刘竞,马志伟,等.腹腔镜与机器人辅助腹腔镜前列腺癌根治术治疗前列腺癌的效果比较[J].广东医学,2017,38(4):563-566.[9]宋明泽,吴晓娇.机器人辅助腹腔镜前列腺癌根治术治疗老年前列腺癌临床疗效分析[J].中国临床医生杂志,2018,46(4):458-460.[10]Zhao Z,Huang Y,Zhang X,et al.Da Vinci robot-assisted resection to treat abdominal ectopic thyroid: a case report and literature review[J].Gland Surg,2021,10(1):378-385.[11]武鹏,秦卫军,张龙龙,等.机器人辅助前列腺癌根治术治疗大体积前列腺癌的临床应用研究[J].现代肿瘤医学,2018,26(3):409-412.[12]田雪梅,王东,任泽杰,等.达芬奇机器人与腹腔镜前列腺癌根治术的临床效果对比[J] 腹腔镜外科杂志,2017,22(7):486-489.[13]Luciani LG,Mattevi D,Mantovani W,et al.Retropubic, Laparoscopic, and Robot-Assisted Radical Prostatectomy: A Comparative Analysis of the Surgical Outcomes in a Single Regional Center[J].Curr Urol,2017,11(1):36-41.[14]钱麟.达芬奇机器人辅助腹腔镜下前列腺癌根治术中副阴部动脉的保留对术后勃起功能的影响[D].杭州:浙江中医药大学,2023.[15]熊柱凤,汤利萍.达芬奇机器人前列腺癌根治术患者生存质量及影响因素[J].中国老年学杂志,2019,39(2):437-440.[16]Yang R,Lu Z,Gu X,et al.The Effect of an Information Support Program on Self-Efficacy of Prostate Cancer Patients during Hormonal Therapy[J].Asia Pac J Oncol Nurs,2021,8(6):639-652.[17]琚官群,曹万里,汪存洲,等.达芬奇机器人在经尿道前列腺电切术后前列腺癌根治术的临床应用[J].微创泌尿外科杂志,2019,8(3):173-177.[18]朱敏,宋辉,张成.达芬奇机器人辅助腹腔镜行前列腺癌根治术的探讨[J].江西医药,2019,54(12):1483-1484,1496.[19]朱延军,王杭,郭剑明,等.经尿道前列腺切除术后前列腺癌行达芬奇机器人辅助腹腔镜根治性前列腺切除术临床分析[J].临床泌尿外科杂志,2017,32(9):675-677,681.[20]孟锐,孙博,邹练.泌尿外科达芬奇机器人辅助与传统腹腔镜围术期指标比较[J].武警医学,2019,30(6):496-498.

相似文献/References:

[1]袁长翮.超声引导下经直肠前列腺穿刺诊断前列腺癌的价值研究[J].医学信息,2018,31(04):156.[doi:10.3969/j.issn.1006-1959.2018.04.058]
　YUAN Chang-he.The Value of Ultrasound Guided Transrectal Prostate Puncture in the Diagnosis of Prostate Cancer[J].Journal of Medical Information,2018,31(17):156.[doi:10.3969/j.issn.1006-1959.2018.04.058]
[2]廖 祺,黄 一,徐 雪.前列腺癌骨转移的疼痛管理[J].医学信息,2018,31(06):51.[doi:10.3969/j.issn.1006-1959.2018.06.017]
　LIAO Qi,HUANG Yi,XU Xue.Pain Management of Bone Metastasis in Prostate Cancer[J].Journal of Medical Information,2018,31(17):51.[doi:10.3969/j.issn.1006-1959.2018.06.017]
[3]胡春燕,吴天天,王 殊,等.前列腺癌患者自我感受负担及其影响因素研究[J].医学信息,2018,31(13):173.[doi:10.3969/j.issn.1006-1959.2018.13.054]
　HU Chun-yan,WU Tian-tian,WANG Shu,et al.Study on Self-perceived Burden and its Influencing Factors in Patients with Prostate Cancer[J].Journal of Medical Information,2018,31(17):173.[doi:10.3969/j.issn.1006-1959.2018.13.054]
[4]曹志彬,王元天,杨伟忠,等.前列腺健康指数在前列腺癌早期诊断中的价值[J].医学信息,2018,31(23):29.[doi:10.3969/j.issn.1006-1959.2018.23.009]
　CAO Zhi-bin,WANG Yuan-tian,YANG Wei-zhong,et al.The Value of Prostate Health Index in Early Diagnosis of Prostate Cancer[J].Journal of Medical Information,2018,31(17):29.[doi:10.3969/j.issn.1006-1959.2018.23.009]
[5]张 莹,谢 静.前列腺癌预后标志的研究[J].医学信息,2019,32(09):7.[doi:10.3969/j.issn.1006-1959.2019.09.003]
　ZHANG Ying,XIE Jing.Prognostic Markers of Prostate Cancer[J].Journal of Medical Information,2019,32(17):7.[doi:10.3969/j.issn.1006-1959.2019.09.003]
[6]袁也晴,张学齐,汪青蓉,等.KIF14在前列腺癌细胞中的表达及作用[J].医学信息,2019,32(09):68.[doi:10.3969/j.issn.1006-1959.2019.09.022]
　YUAN Ye-qing,ZHANG Xue-qi,WANG Qing-rong,et al.Expression and Role of KIF14 in Prostate Cancer Cells[J].Journal of Medical Information,2019,32(17):68.[doi:10.3969/j.issn.1006-1959.2019.09.022]
[7]王 乾,孙 宾,李殷南,等.尿液中肌氨酸、PCA3mRNA在前列腺癌 早期诊断中的应用[J].医学信息,2019,32(14):175.[doi:10.3969/j.issn.1006-1959.2019.14.059]
　WANG Qian,SUN Bin,LI Yin-nan,et al.Application of Urinary Sarcosine and PCA3mRNA in Early Diagnosis of Prostate Cancer[J].Journal of Medical Information,2019,32(17):175.[doi:10.3969/j.issn.1006-1959.2019.14.059]
[8]李熹阳,谷明宇,华 琳.影响前列腺癌风险的关键基因识别[J].医学信息,2020,33(02):80.[doi:10.3969/j.issn.1006-1959.2020.02.022]
　LI Xi-yang,GU Ming-yu,HUA Lin.Identification of Key Genes Affecting Prostate Cancer Risk[J].Journal of Medical Information,2020,33(17):80.[doi:10.3969/j.issn.1006-1959.2020.02.022]
[9]黄 鹏,廖鑫鑫,陆文宝,等.临床评分系统预测前列腺癌根治术后生化复发的研究[J].医学信息,2020,33(08):76.[doi:10.3969/j.issn.1006-1959.2020.08.025]
　HUANG Peng,LIAO Xin-xin,LU Wen-bao,et al.Clinical Scoring System Predicts the Value of Biochemical Recurrence after Radical Prostatectomy[J].Journal of Medical Information,2020,33(17):76.[doi:10.3969/j.issn.1006-1959.2020.08.025]
[10]陈彦君,刘建萍,龚志勇.预测前列腺癌根治术后生化复发的研究[J].医学信息,2021,34(05):49.[doi:10.3969/j.issn.1006-1959.2021.05.015]
　CHEN Yan-jun,LIU Jian-ping,GONG Zhi-yong.Study on the Prediction of Biochemical Recurrence After Radical Prostatectomy[J].Journal of Medical Information,2021,34(17):49.[doi:10.3969/j.issn.1006-1959.2021.05.015]

更新日期/Last Update: 1900-01-01